| 000 | 01653 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517170904.0 | ||
| 264 | 0 | _c20171010 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2017.07.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVassal, Gilles | |
| 245 | 0 | 0 |
_aOrphan Drug Regulation: A missed opportunity for children and adolescents with cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c10 2017 |
||
| 300 |
_a149-158 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDiffusion of Innovation |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Discovery _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedical Oncology _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOrphan Drug Production _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aPediatrics _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aRegistries |
| 700 | 1 | _aKearns, Pam | |
| 700 | 1 | _aBlanc, Patricia | |
| 700 | 1 | _aScobie, Nicole | |
| 700 | 1 | _aHeenen, Delphine | |
| 700 | 1 | _aPearson, Andy | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 84 _gp. 149-158 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2017.07.021 _zAvailable from publisher's website |
| 999 |
_c27475909 _d27475909 |
||